3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
64
Lung Neoplasms
27
Neoplasms
7
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Neoplasm Metastasis
6
Colorectal Neoplasms
6
Pancreatic Neoplasms
4
Mesothelioma, Malignant
3
Melanoma
3
Colonic Neoplasms
3
Carcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Ovarian Neoplasms
2
Non-squamous Non-small Cell Lung Cancer
2
Neoplasms by Site
2
Mesothelioma
2
Meningeal Carcinomatosis
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Advanced Solid Tumors
2
Adenocarcinoma of Lung
2
Vaccinia
1
Uterine Cervical Neoplasms
1
Thoracic Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Interventions
venetoclax
6
ibrutinib
4
pirtobrutinib
2
Sirolimus
2
Rituximab
2
Mycophenolic Acid
2
Cyclosporine
2
Cyclophosphamide
2
zanubrutinib
1
pembrolizumab
1
loncastuximab tesirine
1
fludarabine phosphate
1
carfilzomib
1
acalabrutinib
1
Whole-Body Irradiation
1
Tacrolimus
1
Specimen Handling
1
Rifaximin
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Etoposide
1
Dexamethasone
1
Cyclosporins
1
Calcium Dobesilate
1
CT-P10
1
Busulfan
1
Biopsy
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Waldenstrom Macroglobulinemia
×
Pemetrexed
×
30 days
×
Clear all
No trials found.